|
Re: is anyone thinking or expecting any movement in the sp or
|
3
|
Resverlogix Corp.
|
Jan 05, 2016 08:31PM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
6
|
Resverlogix Corp.
|
Jun 08, 2020 08:52PM
|
|
Re: Investing in the fog
|
|
Resverlogix Corp.
|
Oct 28, 2016 02:12PM
|
|
Re: Investing in the fog
|
|
Resverlogix Corp.
|
Oct 28, 2016 03:45PM
|
|
Re: I'm anxiously awaiting the next short interest update...
|
2
|
Resverlogix Corp.
|
Jun 11, 2019 03:54PM
|
|
Re: I think we would do way,
|
4
|
Resverlogix Corp.
|
Jan 12, 2021 03:47PM
|
|
Re: https://themarkether...
|
6
|
Resverlogix Corp.
|
Feb 22, 2022 09:32PM
|
|
Re: https://themarkether...
|
4
|
Resverlogix Corp.
|
Feb 22, 2022 10:28PM
|
|
Re: How come?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 28, 2020 06:29PM
|
|
Re: How come?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 27, 2020 12:14PM
|
|
Re: Hold or fold?
|
4
|
Resverlogix Corp.
|
Dec 17, 2020 03:02PM
|
|
Re: Highlights of Webast
|
4
|
Resverlogix Corp.
|
Oct 15, 2016 07:40PM
|
|
Re: Hello? Anyone over here?
|
3
|
Zenith Epigenetics
|
Oct 01, 2016 09:16PM
|
|
Re: GV and BoM
|
3
|
Resverlogix Corp.
|
Sep 01, 2017 09:45PM
|
|
Re: Gut Feeling
|
8
|
Resverlogix Corp.
|
Oct 02, 2019 07:18PM
|
|
Re: Gilead pays $21B for Immunomedics, a single cancer drug (newly approved) for metastic Triple Negative Breast Cancer
|
1
|
Zenith Epigenetics
|
Sep 22, 2020 03:03PM
|
|
Re: Getting over price sensitivity....
|
5
|
Resverlogix Corp.
|
Oct 22, 2016 08:41PM
|
|
Re: futility
|
3
|
Resverlogix Corp.
|
Nov 07, 2016 04:23PM
|
|
Re: Fun and games?
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 08:59PM
|
|
Re: frustrant en taberouaite....got a reply to my follow up email
|
5
|
Resverlogix Corp.
|
Sep 12, 2017 09:26PM
|
